secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0000105770-26-000056
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharmaceutical holds 2026 annual meeting; all proposals pass except shareholder chair proposal
--------------------------------------------------------------------------------

- Eleven directors elected to one-year terms; all received majority support with >57M votes each.
- Non-binding say-on-pay approved with 60.1M for, 3.8M against, 80K abstain.
- Ratification of PwC as auditor for FY2026 passed with 58.5M for, 7.6M against.
- Shareholder proposal for independent board chair policy not approved: 29.6M for, 34.2M against.
- Total shares represented: 66.2M (91.83% of outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/0000105770-26-000056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/wst-20260504.htm
  HTML page:      https://secwatch.observer/filing/0000105770-26-000056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer